Register information Patent

DE file number : 60 2016 027 393.4 (Status: pending/in force, Query started: May 2, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2016 027 393.4
96EP file numberEAKZ16 77 1385.8
86WO file numberWAKZPCT/CN2016/077886
97EP publication numberEPN3279198
87WO publication numberWPN2016155630
54Designation/titleTIKRISTALLFORM VON N-[6-(CIS-FORM-2,6-DIMETHYLMORPHOLIN-4-GRUPPE)PYRIDIN-3-GRUPPE]-2-METHYL-4'-(TRIFLUORMETHOXY)[1,1'-BIPHENYL]-3-FORMAMID-MONOPHOSPHAT UND HERSTELLUNGSVERFAHREN DAFÜR
51IPC main classICM
(ICMV)
C07D 413/04 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
A61K 31/5377 (2006.01), A61P 35/00 (2006.01), A61P 35/02 (2006.01)
22DE application dateDATMar 30, 2016
96EP application dateEATMar 30, 2016
86WO application dateWATMar 30, 2016
43Date of first publicationOTOct 6, 2016
Date of publication of grantPETJan 1, 2020
71/73Applicant/ownerINHSun Pharmaceutical Industries Limited, Mumbai, IN
72InventorINCHEN, Minhua, Suzhou Jiangsu 215123, CN; ZHANG, Yanfeng, Suzhou Jiangsu 215123, CN; LU, Fei, Suzhou Jiangsu 215123, CN; ZHANG, Xiaoyu, Suzhou Jiangsu 215123, CN
Address for service RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB
33
31
32
Foreign priorityPRC
PRNA
PRDA
CN
201510144499
Mar 30, 2015
Due dateFT
FG
Mar 31, 2026
Annual fee for the 11th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003279198A1
Searchable text: EP000003279198A1
Original document: EP000003279198B1
Searchable text: EP000003279198B1
Original document: WO002016155630
Searchable text: WO002016155630
43Date of first publicationEVTOct 6, 2016
Date of the first transfer into DPMAregisterEREGTFeb 7, 2018
Date of the (most recent) update in DPMAregisterREGTApr 3, 2025
(Show all update days)(Hide all update days)
  • Apr 3, 2025
    • Due date: changed
    • Procedures: Procedure relating to PCT application, Publication of PCT application, 06.10.2016: deleted
  • Apr 6, 2024; Apr 5, 2023; May 7, 2022; Apr 7, 2022; Apr 1, 2021; Dec 25, 2020; Nov 19, 2020; Mar 31, 2020; Jan 15, 2020; Dec 18, 2019; Dec 12, 2019; Jun 21, 2018
    • Historical data not available for this/these date(s)
  • Feb 7, 2018
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Oct 6, 2016  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Feb 7, 2018  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA Mar 22, 2018 Mar 22, 2018 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Jan 1, 2020  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant Jan 23, 2020 Jan 23, 2020 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Oct 2, 2020 Dec 24, 2020 Details anzeigen
7 New applicant/owner details New applicant/owner details Apr 6, 2022 May 12, 2022 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTOct 6, 2016
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTFeb 7, 2018
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTMar 22, 2018
Issue numberHN12
YearPJ2018
Publication dateVTMar 22, 2018
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTJan 1, 2020
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTJan 23, 2020
Issue numberHN4
YearPJ2020
Publication dateVTJan 23, 2020
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTOct 2, 2020
Issue numberHN52
YearPJ2020
Publication dateVTDec 24, 2020
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTDec 25, 2020
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTApr 6, 2022
Issue numberHN19
YearPJ2022
Publication dateVTMay 12, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHSun Pharmaceutical Industries Limited, Mumbai, IN
71/73Previous applicant/ownerINHFCrystal Pharmatech Co., Ltd., Suzhou, Jiangsu, CN
Date of update of the procedureREGTMay 7, 2022